UYEN PHAN: Open Payments
NPI 1669857595 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,379 in 86 payments from 17 companies in 2025. Trend: 2023 $7,748 · 2024 $18,361 · 2025 $11,379
Speaker / faculty: $9,000Food & beverage: $2,156Travel & lodging: $122Education: $100
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 33 | $9,917 |
| Amgen Inc. | 10 | $205 |
| GENZYME CORPORATION | 8 | $202 |
| ABBVIE INC. | 4 | $197 |
| Janssen Biotech, Inc. | 6 | $196 |
| Incyte Corporation | 3 | $167 |
| Regeneron Healthcare Solutions, Inc. | 3 | $99 |
| UCB, Inc. | 3 | $91 |
| E.R. Squibb & Sons, L.L.C. | 3 | $63 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $58 |
Products named: DUPIXENT, OTEZLA, BOTOX, TREMFYA, Opzelura, NEMLUVIO, Bimzelx, Sotyktu.
Industry payments across TX — which companies pay providers there.
